1038393-19-9

Basic information

• Product Name: IMidazo[1,2-a]pyridine-2-carboxylic acid, 8-broMo-, ethyl ester
• Synonyms: IMidazo[1,2-a]pyridine-2-carboxylic acid, 8-broMo-, ethyl ester;8-broMo-iMidazo(1,2-a)pyridine-2-carboxylic acid ethyl ester;ethyl 8-bromoimidazo[1,2-a]pyridine-2-carboxylate
• CAS NO: 1038393-19-9
• Molecular Formula: C₁₀H₉BrN₂O₂
• Molecular Weight: 269.09466
• Mol File: 1038393-19-9.mol

Chemical Properties

• Appearance: /
• Density: 1.60±0.1 g/cm3(Predicted)
• PKA: 0.33±0.50(Predicted)
• CAS DataBase Reference: IMidazo[1,2-a]pyridine-2-carboxylic acid, 8-broMo-, ethyl ester(CAS DataBase Reference)
• NIST Chemistry Reference: IMidazo[1,2-a]pyridine-2-carboxylic acid, 8-broMo-, ethyl ester(1038393-19-9)
• EPA Substance Registry System: IMidazo[1,2-a]pyridine-2-carboxylic acid, 8-broMo-, ethyl ester(1038393-19-9)

Safety Data

• Hazardous Substances Data: 1038393-19-9(Hazardous Substances Data)

Usage

Uses

Used in Pharmaceutical Synthesis:
IMidazo[1,2-a]pyridine-2-carboxylic acid, 8-broMo-, ethyl ester is used as a key intermediate in the synthesis of various pharmaceutical compounds. Its unique chemical structure allows it to be a valuable building block for the development of new drugs with potential therapeutic applications.
Used in Medicinal Chemistry and Drug Discovery:
In the field of medicinal chemistry, IMidazo[1,2-a]pyridine-2-carboxylic acid, 8-broMo-, ethyl ester is utilized as a starting material for the design and synthesis of novel drug candidates. Its potential biological activity makes it a promising candidate for further research and development in drug discovery.
Used in Chemical Research:
IMidazo[1,2-a]pyridine-2-carboxylic acid, 8-broMo-, ethyl ester is also employed in chemical research for studying its reactivity, stability, and potential applications in various chemical reactions. Its unique properties make it an interesting subject for scientific investigation and exploration of new chemical pathways.
Used in the Treatment of Various Diseases:
Although not explicitly mentioned in the provided materials, the potential biological activity of IMidazo[1,2-a]pyridine-2-carboxylic acid, 8-broMo-, ethyl ester suggests that it may have applications in the treatment of various diseases. Further research and development are required to explore its therapeutic potential and establish its efficacy in specific medical conditions.

Upstream product

• 13534-99-1 2-Amino-3-bromopyridine 
• 70-23-5 ethyl Bromopyruvate 

Downstream Products

• 1026201-45-5 8-bromo-imidazo(1,2-a)pyridine-2-carboxylic acid 

Relevant articles and documents

METALLO-BETA-LACTAMASE INHIBITORS

The present invention relates to compounds of formula I that are metallo-β-lactamase inhibitors, the synthesis of such compounds, and the use of such compounds for use with β-lactam antibiotics for overcoming resistance.

SUBSTITUTED BICYCLIC IMIDAZOLE DERIVATIVES AS GAMMA SECRETASE MODULATORS

The present invention is concerned with novel substituted bicyclic imidazole derivatives of Formula (I) wherein R0, R1, R3, R4, X, A1, A2, A3, A4, Y1, Y2 and Y3 have the meaning defined in the claims. The compounds according to the present invention are useful as gamma secretase modulators. The invention further relates to processes for preparing such novel compounds, pharmaceutical compositions comprising said novel compound as an active ingredient as well as the use of said compounds as a medicament.

HCV NS3 PROTEASE INHIBITORS

The present invention relates to macrocyclic compounds of formula (I) that are useful as inhibitors of the hepatitis C virus (HCV) NS3 protease, their synthesis, and their use for treating or preventing HCV infections.